The ACR/CHEST ILD Guidelines in Practice: Register Now for This Informative Webinar

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Top Research in Psoriatic Arthritis Presented at ACR Convergence 2024

David S. Pisetsky, MD, PhD  |  Issue: December 2024  |  

References

  1. Coates L, Selmi C, Mease P, et al. Sex-related differences in baseline patient and disease characteristics: Post hoc analyses of three phase 3, randomized, double-blind, placebo-controlled studies in patients with active psoriatic arthritis [abstract]. Arthritis Rheumatol. 2024;76(suppl 9).
  2. Nielung L, Hetland M, Skov L, et al. Are patient-reported outcomes for dactylitis, uveitis, psoriatic skin and nail disease valid in patients with psoriatic arthritis? [abstract]. Arthritis Rheumatol. 2024;76(suppl 9).
  3. Maroof A, Ziade N, El Kibbi L, et al. Frequency of fibromyalgia using validated measures in a sample of patients with psoriatic arthritis and impact on disease: A cross-sectional multinational study [abstract]. Arthritis Rheumatol. 2024;76(suppl 9).
  4. Kharouf F, Maldonado Ficco H, Gao S, et al. The association of cigarette smoking with radiographic progression in psoriatic arthritis [abstract]. Arthritis Rheumatol. 2024;76(suppl 9).
  5. Anumolu N, Rosenthal A, Sherman K, Singla S. Higher rates of psoriatic arthritis in patients with calcium pyrophosphate deposition disease than controls: A retrospective cohort study in US veterans [abstract]. Arthritis Rheumatol. 2024;76(suppl 9).
  6. Amin H, Bukhari M. Predictors and patterns of fragility fracture in an observational cohort of patients with psoriatic arthritis [abstract]. Arthritis Rheumatol. 2024;76(suppl 9).
  7. Kerschbaumer A, Steiner M, Khalili S, et al. Global recruiting patterns are associated with placebo response rates in clinical trials of psoriatic arthritis [abstract]. Arthritis Rheumatol. 2024;76(suppl 9).
  8. Esmaeili M, Truong L, Ridolfi N, et al. The effect of systemic immunosuppressive therapies on cardiovascular risk in psoriatic arthritis patients [abstract]. Arthritis Rheumatol. 2024;76(suppl 9).
  9. Eder L, Acayaba de Toledo R, Afgani F, et al. Diagnostic ultrasound enthesitis tool (DUET) for psoriatic arthritis: The distribution of elementary lesions is influenced by site [abstract]. Arthritis Rheumatol. 2024;76(suppl 9).
  10. Ramírez J, Torrente-Segarra V, Cuervo A, et al. Active hand inflammation: Differing clinical and ultrasound patterns in patients with rheumatoid arthritis and psoriatic arthritis. A cross-sectional and multicenter study [abstract]. Arthritis Rheumatol. 2024;76(suppl 9).

Related Articles

    The Heterogeneity of Psoriatic Arthritis

    SAN DIEGO—Differences between psoriatic arthritis and rheumatoid arthritis highlight the need for the development of imaging modalities, laboratory tests and other biomarkers that are explored and validated specifically for PsA to advance the goal of personalized or precision medicine. In this article, expert David S. Pisetsky, MD, PhD, explores the top research in psoriatic arthritis presented at ACR Convergence 2023.

    Top Research in Rheumatoid Arthritis Presented at ACR Convergence 2024

    Why this research is relevant to clinicians today & researchers in the future WASHINGTON, D.C.—The ACR Convergence 2024 meeting in Washington, D.C., reflected the continued advancement of science and practical research in the field of rheumatoid arthritis. Highlights this year centered on new RA treatments and new uses of existing treatments; the use of artificial…

    Case Report: A Psoriatic Arthritis Patient with Dactylitis & Enthesitis

    A 36-year-old woman presented at the Johns Hopkins Arthritis Center for a second opinion regarding a diagnosis of psoriatic arthritis (PsA). One year prior to our evaluation, she had developed pain and stiffness in her hands, feet, knees, ankles, elbows and shoulders. She had mild plaque psoriasis of the scalp and base of the neck,…